Piramal Pharma exercises call option to acquire balance 26% stake in Yapan Bio
Mumbai, Nov. 18 -- Piramal Pharma, acting under the authority delegated by the Board, has approved the exercise of the Company's call option to acquire the balance 26% equity stake in Yapan Bio (Yapan), a subsidiary of the Company, from its existing shareholders (the Proposed Transaction).
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.